Publications by authors named "Kevin Church"

Claim this Profile
F
Fosgonimeton in mild-to-moderate Alzheimer's disease.
Anton P Porsteinsson, Marwan Sabbagh, Pierre N Tariot, Kevin J Church, Javier San Martin

J Alzheimers Dis Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the impact of vaccine hesitancy on an emerging infectious disease: a mathematical and numerical analysis.
Indunil M Hewage, Kevin E M Church, Elissa J Schwartz

J Biol Dyn· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease.
Sherif M Reda, Sharay E Setti, Andrée-Anne Berthiaume, Wei Wu, Robert W Taylor, Kevin J Church

Neurotherapeutics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, is neuroprotective, preserves neuromotor function, and extends survival in preclinical models of ALS.
Andrée-Anne Berthiaume, Sherif M Reda, Kayla N Kleist, Sharay E Setti, Wei Wu, Kevin J Church

Front Neurosci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computer-Assisted Proofs of Hopf Bubbles and Degenerate Hopf Bifurcations.
Kevin Church, Elena Queirolo

J Dyn Differ Equ· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia.
Jewel L Johnston, Sherif M Reda, Sharay E Setti, Robert W Taylor, Andrée-Anne Berthiaume, Kevin J Church

Neurotherapeutics· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators.
Hans J Moebius, Kevin J Church

J Alzheimers Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential.
John Olichney, Jiangyi Xia, Kevin J Church, Hans J Moebius

Neural Plast· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.
Xue Hua, Kevin Church, William Walker, Philippe L'Hostis, Geoffrey Viardot

J Alzheimers Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocyte Growth Factor and Macrophage-stimulating Protein "Hinge" Analogs to Treat Pancreatic Cancer.
John W Wright, Kevin J Church, Joseph W Harding

Curr Cancer Drug Targets· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.
Brett R Vanderwerff, Kevin J Church, Leen H Kawas, Joseph W Harding

Cytokine· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine.
Kevin J Church, Brett R Vanderwerff, Rachelle R Riggers, Beatriz Mateo-Victoriano, Matthew Fagnan

Anticancer Drugs· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells.
Kevin J Church, Brett R Vanderwerff, Rachelle R Riggers, Michelle D McMicheal, Beatriz Mateo-Victoriano

Anticancer Drugs· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing malaria surveillance with periodic spraying in the presence of insecticide-resistant mosquitoes: Should we spray regularly or based on human infections?
Kevin E M Church, Robert J Smith

Math Biosci· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study to determine the clinical significance of HEmolysis During Orbital AtheRectomy (CLEAR study).
Cezar S Staniloae, Ravikiran Korabathina, Thomas A Lane, Raymond Dattilo, Kevin J Church

J Endovasc Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient pyrimidine N-1-alkylation via activation of electron rich olefins with oxoammonium salts: synthesis of methoxy TEMPO substituted pyrimidine nucleoside analogs.
Kevin M Church, Liesel M Holloway, Ryan C Matley, Robert J Brower

Nucleosides Nucleotides Nucleic Acids· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis